Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01246713 · ClinicalTrials.gov registry record · NA
Effect on Acetaminophen Metabolism by Liquid Formulations
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01246713 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 15 participants.
The verdict
NCT01246713, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether excipients in the liquid formulation of acetaminophen prevent the formation of the toxic metabolites of acetaminophen.
Interventions
- DRUG Acetaminophen liquid formulation
- DRUG Acetaminophen solid formulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01246713
The ClinicalTrials.gov registry entry for NCT01246713 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen liquid formulation is the first listed.
NCT01246713 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01246713 about?
NCT01246713 is a clinical study titled "Effect on Acetaminophen Metabolism by Liquid Formulations". The purpose of this study is to determine whether excipients in the liquid formulation of acetaminophen prevent the formation of the toxic metabolites of acetaminophen.
What is the current status of trial NCT01246713?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2010-12. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01246713?
The interventions under investigation include: Acetaminophen liquid formulation (DRUG), Acetaminophen solid formulation (DRUG).
Who is sponsoring clinical trial NCT01246713?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.